South Korea · Delayed Price · Currency is KRW Genotech Company Description
Genotech Corporation provides products and services for gene synthesis, genome analysis, and biopharmaceuticals in South Korea and internationally.
The company offers standard, modified, dual labeled, and synthesis oligonucleotides; and gene synthesis services.
It also provides sanger DNA sequencing services, which includes standard DNA, 16S/ITS, and insert clone sequencing, as well as primer walking; next generation sequencing; bioinformatics services; genomic services, such as SNP discovery/analysis and sequence finishing; and molecular diagnostic kits.
In addition, the company provides active pharmaceutical ingredients, such as vancomycin HCI, teicoplanin, and tacrolimus.
Further, its bio-pharma research activities include development of incrementally modified drug and identification of new molecular entities through its functional genomics and metabolic reconstruction technologies.
Genotech Corporation was founded in 1997 and is headquartered in Daejeon, South Korea.
| Country | South Korea |
| Founded | 1997 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: 26-69, Gajeongbuk-ro Daejeon, 305-343 South Korea | |
| Phone | 82 4 2862 8404 |
| Website | genotech.co.kr |
Stock Details
| Ticker Symbol | 066830 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |